8-K/A

FORM 8-K/A

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: March 22, 2012
Period of Report: March 21, 2012
Accession Number: 0001144204-12-016644

View Document ↗ View on SEC.gov ↗